Michael Krummhaar

This paper investigates the conformational dynamics of plasmepsin X during inhibitor binding and unbinding using molecular dynamics simulations, revealing a dominant unbinding pathway involving flap conformational changes.

This paper develops and characterizes novel monoclonal antibodies against sLeA, showing improved affinity and specificity compared to existing antibodies.